High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine

This publication has 20 references indexed in Scilit:

• Post-operative intrapleural BCG in lung cancer: A 5-year follow-up report
  Cancer Immunology, Immunotherapy, 1986
• Tumor-associated macrophages stimulate the proliferation of murine tumor cells surviving treatment with the oncolytic cyclophosphamide analogue ASTA Z-7557:In vivo implications
  International Journal of Cancer, 1984
• Immunoregulatory T-Cell Pathways
  Annual Review of Immunology, 1983
• Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity
  British Journal of Cancer, 1978
• Effect of BCG on Alloimmune Cell-Mediated Cytotoxicity in (C57BL/6J ♀ × A/J ♂)F1 Mice. II. Correlation With BCG Activity in Syngeneic Tumor Systems2
  JNCI Journal of the National Cancer Institute, 1978
• Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma
  British Journal of Cancer, 1976
• BCG Immunopotentiation of an Antitumor Response: Evidence for a Cell-Mediated Mechanism 2
  JNCI Journal of the National Cancer Institute, 1975
• Facilitation and inhibition of B16 melanoma by BCG in vivo and by lymphoid cells from BCG‐treated mice in vitro
  International Journal of Cancer, 1974
• BCG Immunotherapy of Pulmonary Growths from Intravenously Transferred Rat Tumour Cells
  British Journal of Cancer, 1973
• Inhibitory effects of BCG on adenovirus tumorigenesis: Dependence on administration schedule
  International Journal of Cancer, 1972